Does changing androgen receptor status during prostate cancer development impact upon cholesterol homeostasis?

ABSTRACT:

Background

Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an important raw material for cell-growth. Within the cell, cholesterol homeostasis is maintained by two master transcription factors: sterol-regulatory element-binding protein 2 (SREBP-2) and liver X receptor (LXR). We previously showed that the androgen receptor, a major player in prostate cell physiology, toggles these transcription factors to promote cholesterol accumulation. Given that prostate cancer therapy targets the androgen receptor, selecting for cells with altered androgen receptor activity, how would this affect SREBP-2 and LXR activity? Using a novel prostate cancer progression model, we explored how this crosstalk between the androgen receptor and cholesterol h

SUBMITTER: Krycer JR 

PROVIDER: S-EPMC3540066 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature